Survey: Doctors say Medicare anemia-drug policy hurts patient care

02/19/2008 | American Medical News (subscription required)

Doctors believe Medicare's policy for drug treatment for anemic cancer is negatively affecting patient care, according to a survey sponsored by U.S. Oncology. The results showed 91% of doctors reported adverse patient events in the 12 weeks after the policy's July 30 implementation. Seventy-three percent of respondents said a transfusion could have been avoided if Medicare's previous coverage policy had still been in place.

View Full Article in:

American Medical News (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL